Revision as of 18:39, 28 February 2011 editYikrazuul (talk | contribs)Rollbackers1,991 editsm svg← Previous edit |
Latest revision as of 20:54, 14 May 2024 edit undoSpiderpig662 (talk | contribs)Extended confirmed users12,855 editsm Removed duplicate tagTag: Manual revert |
(18 intermediate revisions by 17 users not shown) |
Line 1: |
Line 1: |
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 384093002 |
|
|
|
| Watchedfields = changed |
⚫ |
|ImageFile=Dihydrouracil.svg |
|
|
⚫ |
| verifiedrevid = 416414074 |
⚫ |
|ImageSize=120px |
|
|
⚫ |
| ImageFile=Dihydrouracil.svg |
|
|IUPACName=hexahydropyrimidine-2,4-dione |
|
|
⚫ |
| ImageSize=120px |
|
|OtherNames= |
|
|
|
| PIN = 1,3-Diazinane-2,4-dione |
|
|
| OtherNames= Dihydropyrimidine-2,4(1''H'',3''H'')-dione |
|
|Section1={{Chembox Identifiers |
|
|Section1={{Chembox Identifiers |
|
|
| CASNo_Ref = {{cascite|correct|??}} |
|
| CASNo=504-07-4 |
|
| CASNo=504-07-4 |
⚫ |
| PubChem=649 |
|
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
⚫ |
| SMILES=C1CNC(=O)NC1=O |
|
|
|
| UNII = 016FR52RU5 |
⚫ |
| MeSHName=Dihydrouracil |
|
|
⚫ |
| PubChem=649 |
|
⚫ |
| SMILES=C1CNC(=O)NC1=O |
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
|
| ChemSpiderID = 629 |
|
|
| InChI = 1/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8) |
|
|
| InChIKey = OIVLITBTBDPEFK-UHFFFAOYAM |
|
|
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|
|
| StdInChI = 1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8) |
|
|
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|
|
| StdInChIKey = OIVLITBTBDPEFK-UHFFFAOYSA-N |
|
⚫ |
| MeSHName=Dihydrouracil |
|
}} |
|
}} |
|
|Section2={{Chembox Properties |
|
|Section2={{Chembox Properties |
|
| Formula=C<sub>4</sub>H<sub>6</sub>N<sub>2</sub>O<sub>2</sub> |
|
| Formula=C<sub>4</sub>H<sub>6</sub>N<sub>2</sub>O<sub>2</sub> |
|
| MolarMass=114.10264 |
|
| MolarMass=114.10264 |
|
| Appearance= |
|
| Appearance= |
|
| Density= |
|
| Density= |
|
| MeltingPt= |
|
| MeltingPt= |
|
| BoilingPt= |
|
| BoilingPt= |
|
| Solubility= |
|
| Solubility= |
|
}} |
|
}} |
|
|Section3={{Chembox Hazards |
|
|Section3={{Chembox Hazards |
|
| MainHazards= |
|
| MainHazards= |
|
| FlashPt= |
|
| FlashPt= |
|
|
| AutoignitionPt = |
|
| Autoignition= |
|
|
}} |
|
}} |
|
}} |
|
}} |
|
|
|
|
|
|
'''Dihydrouracil''' is an intermediate in the catabolism of ].<ref>{{cite journal |last1=Nakamura |first1=A |last2=Kikuchi |first2=K |last3=Ohishi |first3=T |last4=Masuike |first4=T |title=. |journal=Gan to Kagaku Ryoho. Cancer & Chemotherapy |date=March 2004 |volume=31 |issue=3 |pages=381–6 |pmid=15045945}}</ref> It is the base present in the ] ]. |
|
'''Dihydrouracil''' is an intermediate in the catabolism of ]. |
|
|
|
|
|
|
==See also== |
|
==See also== |
Line 33: |
Line 46: |
|
* ] |
|
* ] |
|
* ] |
|
* ] |
|
|
==References== |
|
|
|
|
|
{{reflist}} |
|
{{Nucleotide metabolism intermediates}} |
|
{{Nucleotide metabolism intermediates}}{{Nucleobases, nucleosides, and nucleotides}} |
|
|
|
|
|
] |
|
] |
|
] |
|
] |
|
] |
Line 41: |
Line 55: |
|
|
|
|
|
{{organic-compound-stub}} |
|
{{organic-compound-stub}} |
|
|
|
|
] |
|